Literature DB >> 32958592

Ataxia telangiectasia: what the neurologist needs to know.

May Yung Tiet1, Rita Horvath1, Anke E Hensiek2,3.   

Abstract

Ataxia telangiectasia is an autosomal recessive DNA repair disorder characterised by complex neurological symptoms, with an elevated risk of malignancy, immunodeficiency and other systemic complications. Patients with variant ataxia telangiectasia-with some preserved ataxia telangiectasia-mutated (ATM) kinase activity-have a milder and often atypical phenotype, which can lead to long delays in diagnosis. Clinicians need to be aware of the spectrum of clinical presentations of ataxia telangiectasia, especially given the implications for malignancy surveillance and management. Here, we review the phenotypes of ataxia telangiectasia, illustrated with case reports and videos, and discuss its pathological mechanisms, diagnosis and management. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  GENETICS

Mesh:

Year:  2020        PMID: 32958592     DOI: 10.1136/practneurol-2019-002253

Source DB:  PubMed          Journal:  Pract Neurol        ISSN: 1474-7758


  2 in total

1.  White Matter Hyperintensities and Cerebral Microbleeds in Ataxia-Telangiectasia.

Authors:  May Yung Tiet; Stefania Nannoni; Daniel Scoffings; Katherine Schon; Rita Horvath; Hugh Stephen Markus; Anke Erma Hensiek
Journal:  Neurol Genet       Date:  2021-11-30

2.  Childhood-Onset Movement Disorders Can Mask a Primary Immunodeficiency: 6 Cases of Classical Ataxia-Telangiectasia and Variant Forms.

Authors:  Geraldine Blanchard-Rohner; Anna Peirolo; Ludivine Coulon; Christian Korff; Judit Horvath; Pierre R Burkhard; Fabienne Gumy-Pause; Emmanuelle Ranza; Peter Jandus; Harpreet Dibra; Alexander Malcolm R Taylor; Joel Fluss
Journal:  Front Immunol       Date:  2022-01-28       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.